
Sign up to save your podcasts
Or


If the past year has shown us anything, it’s that GLP-1s are here to stay. But as time passes, we’re also learning more about them — from new uses to new side effects to unexpected cultural trends. So have these drugs really lived up to the promise of easy weight loss?
On this episode of Health Matters, Mayo Clinic dietitian Tara Schmidt rejoins us — one year after our original GLP-1 episode — to talk about what we’ve learned so far, what’s surprised researchers and patients, and what questions still need answers.
By Mayo Clinic Press4.8
8181 ratings
If the past year has shown us anything, it’s that GLP-1s are here to stay. But as time passes, we’re also learning more about them — from new uses to new side effects to unexpected cultural trends. So have these drugs really lived up to the promise of easy weight loss?
On this episode of Health Matters, Mayo Clinic dietitian Tara Schmidt rejoins us — one year after our original GLP-1 episode — to talk about what we’ve learned so far, what’s surprised researchers and patients, and what questions still need answers.

321 Listeners

974 Listeners

701 Listeners

504 Listeners

870 Listeners

3,374 Listeners

490 Listeners

1,150 Listeners

696 Listeners

94 Listeners

141 Listeners

518 Listeners

367 Listeners

437 Listeners

114 Listeners